Histone deacetylases (HDACs) are epigenetic erasers, which are considered as transcriptional repressors and potent anticancer targets. Today, 18 human HDACs are identified and divided in four classes. FDA has approved four Histone Deacetylase Inhibitors (HDACi), defined as pan-HDAC inhibitors...
Source:
3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13, 2016
TY - CONF
AU - Ružić, Dušan
AU - Nikolić, Katarina
AU - Agbaba, Danica
AU - Ganesan, A.
PY - 2016
UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5028
AB - Histone deacetylases (HDACs) are epigenetic erasers, which are considered as transcriptional repressors and potent anticancer targets. Today, 18 human HDACs are identified and divided in four classes. FDA has approved four Histone Deacetylase Inhibitors (HDACi), defined as pan-HDAC inhibitors...
PB - Freiburg Institute for Advanced Studies
C3 - 3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13
T1 - Computer aided drug design – a step closer to selective HDAC-6 inhibitor?
UR - https://hdl.handle.net/21.15107/rcub_farfar_5028
ER -
@conference{
author = "Ružić, Dušan and Nikolić, Katarina and Agbaba, Danica and Ganesan, A.",
year = "2016",
abstract = "Histone deacetylases (HDACs) are epigenetic erasers, which are considered as transcriptional repressors and potent anticancer targets. Today, 18 human HDACs are identified and divided in four classes. FDA has approved four Histone Deacetylase Inhibitors (HDACi), defined as pan-HDAC inhibitors...",
publisher = "Freiburg Institute for Advanced Studies",
journal = "3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13",
title = "Computer aided drug design – a step closer to selective HDAC-6 inhibitor?",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5028"
}
Ružić, D., Nikolić, K., Agbaba, D.,& Ganesan, A.. (2016). Computer aided drug design – a step closer to selective HDAC-6 inhibitor?. in 3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13
Freiburg Institute for Advanced Studies..
https://hdl.handle.net/21.15107/rcub_farfar_5028
Ružić D, Nikolić K, Agbaba D, Ganesan A. Computer aided drug design – a step closer to selective HDAC-6 inhibitor?. in 3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13. 2016;.
https://hdl.handle.net/21.15107/rcub_farfar_5028 .
Ružić, Dušan, Nikolić, Katarina, Agbaba, Danica, Ganesan, A., "Computer aided drug design – a step closer to selective HDAC-6 inhibitor?" in 3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13 (2016),
https://hdl.handle.net/21.15107/rcub_farfar_5028 .
